NCT05230810 2026-03-16Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.Criterium, Inc.Phase 1/2 Active not recruiting40 enrolled
NCT04778982 2023-07-17Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast CancerJiangsu Alphamab Biopharmaceuticals Co., LtdTerminated4 enrolled